Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasopharyngeal pneumococcal colonization in infants after 3+1 Prevenar schedule
2008-000083-17Phase 3
- Sponsor
- Nederlands Vaccin Instituut
- Start
- May 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of pneumococcal 7-valent conjugate vaccine in pneumococcal disease, sponsored by Nederlands Vaccin Instituut. Primary endpoint: Vaccine-type nasopharyngeal colonization at 12 months.
02
Drugs
pneumococcal 7-valent conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on 2008-000083-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000083-17.